Dylus, David https://orcid.org/0000-0002-0327-0781
Altenhoff, Adrian https://orcid.org/0000-0001-7492-1273
Majidian, Sina https://orcid.org/0000-0001-5345-6982
Sedlazeck, Fritz J. https://orcid.org/0000-0001-6040-2691
Dessimoz, Christophe https://orcid.org/0000-0002-2170-853X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (UM1HG008898)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1U19AI144297)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (183723, 205085)
Article History
Received: 18 April 2022
Accepted: 16 March 2023
First Online: 20 April 2023
Competing interests
: F.J.S. receives research funding from Oxford Nanopore and Pacific Biosciences. C.D. served as expert witness for Pacific Biosciences. The remaining authors declare no competing interests.